We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
-2.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$2.77B
AUM Growth
-$1.58B
Cap. Flow
-$2B
Cap. Flow %
-72%
Top 10 Hldgs %
42.37%
Holding
344
New
73
Increased
57
Reduced
60
Closed
118

Sector Composition

Rank Sector Weight
1 Communication Services 28.08%
2 Technology 11.5%
3 Financials 7.82%
4 Industrials 6.62%
5 Healthcare 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RETA
151
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$964K 0.03%
17,178
+4,874
+40% +$298K
FTR
152
PUT
DELISTED
Frontier Communications Corp.
FTR
$891K 0.03%
469,000
+35,000
+8% +$148K
HR icon
153
Healthcare Realty
HR
$6.92B
$886K 0.03%
35,000
-112,300
-76% -$2.98M
SMTA
154
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$870K 0.03%
122,000
+72,000
+144% +$729K
MRAM icon
155
Everspin Technologies
MRAM
$367M
$843K 0.03%
150,310
-4,500
-3% -$30.8K
VKTX icon
156
Viking Therapeutics
VKTX
$3.88B
$787K 0.03%
102,842
+7,842
+8% +$93.8K
GLMD icon
157
Galmed Pharmaceuticals
GLMD
$4.95M
$726K 0.03%
591
-62
-9% -$108K
BB icon
158
BlackBerry
BB
$5.15B
$711K 0.03%
100,000
-50,000
-33% -$440K
URGN icon
159
UroGen Pharma
URGN
$2.22B
$700K 0.03%
16,250
-6,409
-28% -$288K
REPL icon
160
Replimune Group
REPL
$1.08B
$685K 0.02%
68,531
+15,866
+30% +$214K
CRSP icon
161
CRISPR Therapeutics
CRSP
$4.99B
$638K 0.02%
22,319
-7,681
-26% -$267K
O icon
162
Realty Income
O
$58.2B
$630K 0.02%
+10,320
New +$616K
USO icon
163
PUT
United States Oil Fund
USO
$1.86B
$605K 0.02%
+250,000
New +$25.2M
NFLX icon
164
PUT
Netflix
NFLX
$307B
$589K 0.02%
+100,000
New +$2.99M
JNK icon
165
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.91B
$575K 0.02%
+333,333
New +$34.8M
CUBE icon
166
CubeSmart
CUBE
$9.42B
$574K 0.02%
+20,000
New +$587K
WUBA
167
DELISTED
58.com Inc
WUBA
$573K 0.02%
+10,562
New +$644K
EQIX icon
168
Equinix
EQIX
$104B
$564K 0.02%
1,600
-5,450
-77% -$2.12M
GCVRZ
169
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$558K 0.02%
1,162,096
VERU icon
170
Veru
VERU
$37.1M
$545K 0.02%
38,961
-274
-0.7% -$3.78K
ADT icon
171
ADT
ADT
$5.59B
$541K 0.02%
90,000
BBGI icon
172
Beasley Broadcasting Group
BBGI
$42.8M
$527K 0.02%
7,032
-4,218
-37% -$476K
ATHM icon
173
Autohome
ATHM
$2.62B
$508K 0.02%
+6,500
New +$490K
FRT icon
174
Federal Realty Investment Trust
FRT
$10.2B
$496K 0.02%
4,200
-35,500
-89% -$4.46M
ITRM
175
DELISTED
Iterum Therapeutics
ITRM
$496K 0.02%
6,601
-66
-1% -$6.25K

Similar funds

UBS O'Connor's Q4 2018 Portfolio in Review

As of Q4 2018, UBS O'Connor held 344 positions worth $2.77B, down 36% from $4.35B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

UBS O'Connor withdrew a net $2B in Q4 2018, closing 118 positions and reducing 60 holdings. Its most notable exit was Aetna Inc, an estimated $427M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, UBS O'Connor opened a new position in Red Hat Inc worth $165M.

  • UBS O'Connor's largest Q4 2018 buy was Red Hat Inc: 937,711 shares worth $165M.
  • UBS O'Connor added most to Twenty-First Century Fox, Inc. Class A in Q4 2018, an estimated $51.2M increase.
  • UBS O'Connor's biggest Q4 2018 reduction was Dell, cutting an estimated $50.9M.
  • UBS O'Connor fully exited Aetna Inc in Q4 2018, selling an estimated $427M.
  • UBS O'Connor's ten largest holdings make up 42% of its $2.77B portfolio in Q4 2018.
  • UBS O'Connor opened 73 new positions and closed 118 in Q4 2018.
  • UBS O'Connor's portfolio value fell 36% quarter-over-quarter to $2.77B.

Based on UBS O'Connor's 13F filing for Q4 2018, filed 15 Feb 2019.